Literature DB >> 26714547

[Molecular characteristics of Clustered Regularly Interspaced Short Palindromic Repeat in Shigella].

Zerun Xue1, Yingfang Wang2, Guangcai Duan3, Haiyan Yang4, Yuanlin Xi4, Pengfei Wang4, Linlin Wang4, Xiangjiao Guo4.   

Abstract

OBJECTIVE: To detect the molecular characteristics of Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) in Shigella and to analyze the distribution of CRISPR related to the time of isolation.
METHODS: Of the 52 Shigella strains, 41 were isolated from Henan, 6 from Jiangxi and 5 isolated from Beijing. Both CRISPR locus of S1, S2, S3 and S4 in Shigella were detected by polymerase chain reaction (PCR). The PCR products were sequenced and compared.
RESULTS: The positive rates of CRISPR locus in Shigella were 33.69% (S1), 50.00% (S2), 82.69% (S3) and 73.08% (S4), respectively. Two subtypes were discovered in S1 and S3 locus. Three subtypes were discovered in S2 locus. Four different subtypes were discovered in S4 locus. The isolates from Henan strains were divided into two groups by the time of isolation. Distributions of S1 were different, before or after 2004, on Shigella. S1 could not be detected after 2004. There were no statistical differences of S2, S3 and S4 in two groups.
CONCLUSION: Different CRISPR subtypes or Shigella were discovered. A significant correlation was noticed between the CRISPR S1 related to the time of isolation but not between S2, S3 or S4 on the time of isolation.

Entities:  

Mesh:

Year:  2015        PMID: 26714547

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  1 in total

1.  Relationship between drug resistance and the clustered, regularly interspaced, short, palindromic repeat-associated protein genes cas1 and cas2 in Shigella from giant panda dung.

Authors:  Lu Ren; Lin-Hua Deng; Ri-Peng Zhang; Cheng-Dong Wang; De-Sheng Li; Li-Xin Xi; Zhen-Rong Chen; Rui Yang; Jie Huang; Yang-Ru Zeng; Hong-Lin Wu; San-Jie Cao; Rui Wu; Yong Huang; Qi-Gui Yan
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.